Delivery Order SPE2DB20D1109-SPE2DB23FN54A

Award Date 2/13/23
Potential Completion Date 2/14/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,468.60 delivery order covers the supply of Epinephrine 0.3 mg auto-injectors, a critical medication for emergency medical care. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,889.12 firm-fixed-price delivery order is for the supply of Epinephrine 0.15 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award, valued at $8,464.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4,562,581,703 units of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, provides for the delivery of Epinephrine 0.3 mg auto-injectors. The $2,029.99 firm-fixed-price delivery order is placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Cencora, Inc. to supply a wide range of pharmaceutical products and medical...
This federal contract award, valued at $3,349.43, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award, valued at $31,417.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $1,194.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical commodity used for the emergency treatment of severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award, valued at $1,791.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a completion date of May 1, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of epinephrine 0.3 mg auto-injectors. The $3,665.82 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,429.96 Firm Fixed Price Delivery Order covers the supply of 4,562,239,834 units of Epinephrine 0.3 mg Auto-Injectors for a period ending on September 21, 2023. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Cencora, Inc., doing business as Amerisourcebergen, holds...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FN54A
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,093.26 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition.

In addition to the DLA IDC, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse pharmaceutical and medical supply needs of multiple government agencies.

Generated 2/27/25, 12:02 PM